STERIALS

The Company's global business involves the discovery, development, manufacture and sale of pharmaceuticals for the human body, and offers a wide range of treatments for a variety of conditions, including diabetes, cancers such as advanced non-small cell lung cancer and advanced non-squamous cell carcinoma, immune disorders such as rheumatoid arthritis and psoriasis vulgaris, migraine and other neurological disorders, as well as the development of treatments for Alzheimer's disease, atopic dermatitis and other conditions.